Master of Science in Infection Biology | Swiss TPH (Page)
https://www.swisstph.ch/fr/study-with-us/bachelor-and-master/msc-in-infection-biology
early male gametocyte-specific protein which can help us further understand transmission stages of malaria. With half the world's population at risk of becoming infected, basic research into the intricate [...] intricate biology of the parasite is crucial.” Patricia Landeau Millan MSc Infection Biology student, Malaria Gene Regulation Unit At a Glance Duration: 3 semesters (90 ECTS) starting from September (Autumn semester)
Impact Stories | Swiss TPH (Page)
https://www.swisstph.ch/fr/impact-stories
research. Read more 22.04.2021 Julia Richter, Swiss Malaria Group World Malaria Day 2021: In the shadows of the COVID-19 pandemic A world without malaria is within reach. At the same time, the COVID-19 pandemic [...] progress in the fight against malaria. This year's World Malaria Day on 25 April 2021 will draw attention to the fact that further efforts are needed to achieve the goal of a malaria-free world. Read more 21 [...] years, much has been invested in malaria prevention and...
Eric Huber (People)
https://www.swisstph.ch/fr/staff/profile/people/eric-huber
monitoring of trials, mainly in resource-limited countries, focusing on neglected diseases such as malaria, tuberculosis and helminth infections. Through this work he has gained extensive experience in the
Science Publication: SARS-CoV-2 Genomic Surveillance in Africa (Page)
https://www.swisstph.ch/fr/science-publication-sars-cov-2-genomic-surveillance-in-africa
set up the Baney Public Health Laboratory as part of the Equatoguinean Malaria Vaccine Initiative to work on the development of malaria vaccines. This laboratory was implemented as early as January 2020 by [...] Africa CDC, WHO AFRO and 300 other institutions across the continent, including Swiss TPH. From Malaria Vaccine Development to SARS-CoV-2 Screening Swiss TPH and partners from Equatorial Guinea contributed
Christian Selinger (People)
https://www.swisstph.ch/fr/staff/profile/people/christian-selinger
in pathogens and diseases affecting humans such as HIV, Influenza, Polio, HPV, Coronaviruses and Malaria.
Symposia Archive (Page)
https://www.swisstph.ch/fr/about/events/symposia-archive
Spring Symposium 2017 - Evidence Meets Decisions Makers Winter Symposium 2016 - Building on Success: Malaria Control and Elimination Spring Symposium 2016 - The Future of Travel Medicine Winter Symposium 2015 [...] Europe and Central Asia: Where do we stand and where to go? Autumn Symposium 2012 - Challenges in Malaria Research: Progress Towards Elimination Spring Symposium 2012 - eHealth in Proof and Practice: Op
Topics we work on | Research Areas at Swiss TPH (Page)
https://www.swisstph.ch/fr/research/research-areas
pharmaceutical, clinical and implementation research - with a focus on poverty-related diseases. Malaria Neglected Tropical Diseases Parasitic Worm Infections Sleeping Sickness Tuberculosis Human Biomonitoring
Medical Services (Page)
https://www.swisstph.ch/fr/about/dir/medical-services
and, on behalf of the Federal Office of Public Health (FOPH), provides reference diagnosis for malaria and confirmatory diagnosis for other non-endemic parasitic diseases as part of the surveillance concept
Research Infrastructure at Swiss TPH | Excellence in Science (Page)
https://www.swisstph.ch/fr/research/research-infrastructure
facility fosters innovation in vector biology and behaviour, enabling the control of diseases such as malaria and dengue fever. In our BSL-3 laboratories, we are driving breakthroughs in drug resistance, diagnostics
Monica Golumbeanu (People)
https://www.swisstph.ch/fr/staff/profile/people/monica-golumbeanu
her research focuses on developing data-driven computational analyses and mathematical models of malaria infection dynamics to assess the impact of interventions on host and parasite populations. Previously
